期刊文献+

宣肺化痰汤加减联合西药治疗慢性阻塞性肺疾病急性加重期临床研究

Clinical Study on Modified Xuanfei Huatan Decoction Combined with Western Medicinefor Acute Exacerbationof Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:观察宣肺化痰汤加减联合西药治疗慢性阻塞性肺疾病急性加重期(AECOPD)痰浊蕴肺证的临床效果。方法:以随机数字表法将124例AECOPD痰浊蕴肺证患者分为观察组(以宣肺化痰汤加减联合西药治疗)和对照组(仅以西药治疗),每组62例。2组均治疗2周后评估临床疗效、中医证候积分、肺功能指标及炎症指标水平。结果:治疗2周后,总有效率观察组95.16%,高于对照组83.87%(P<0.05)。中医证候积分2组均低于治疗前(P<0.05),且观察组低于对照组(P<0.05)。第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、FEV_(1)/FVC、第1秒用力呼气容积占预计值的百分比(FEV_(1)%pred)2组均高于治疗前(P<0.05),且观察组上述4项肺功能指标值均高于对照组(P<0.05)。血清超敏C-反应蛋白(hs-CRP)、白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)水平2组均低于治疗前(P<0.05),且观察组上述3项炎症指标水平均低于对照组(P<0.05)。结论:宣肺化痰汤加减联合西药治疗AECOPD痰浊蕴肺证疗效显著,可有效改善临床症状、肺功能及炎症指标。 Objective:To observe the clinical effect of modified Xuanfei Huatan Decoction combined with western medicine on patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)with syndrome of turbid phlegm accumulation in the lung.Methods:A total of 124 cases of AECOPD patients with syndrome of turbid phlegm accumulation in the lung were randomly divided into the observation group(treated with modified Xuanfei Huatan Decoction combined with western medicine)and the control group(treated with western medicine only),with 62 cases in each group.After two weeks of treatment,both groups were evaluated for clinical effects,traditional Chinese medicine(TCM)syndrome scores,lung function indicators,and serum inflammatory index levels.Results:After two weeks of treatment,the total effective rate in the observation group was better than that in the control group(95.16%vs 83.87%)(P<0.05).The TCM syndrome scores in both groups were lower than those before treatment(P<0.05),and the TCM syndrome scores in the observation group were lower than those in the control group(P<0.05).The forced expiratory volume in one second(FEV_(1)),forced vital capacity(FVC),FEV_(1)/FVC,and the percentage of FEV_(1) to the expected value(FEV_(1)%pred)in both groups were higher than those before treatment(P<0.05);the above four indexes in the observation group were higher than those in the control group(P<0.05).The levels of serum high-sensitivity C-reactive protein(hs-CRP),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)were all lower than those before treatment(P<0.05),and the levels of the above three indicators in the observation group were lower than those in the control group(P<0.05).Conclusion:The combination of modified Xuanfei Huatan Decoction and western medicine has a significant therapeutic effect on AECOPD patients with syndrome of turbid phlegm accumulation in the lung,which has a positive improvement effect on clinical symptoms,lung function and inflammatory indicator.
作者 全燕燕 朱景倩 马正兴 杜旦锋 QUAN Yanyan;ZHU Jingqian;MA Zhengxing;DU Danfeng(Dongyang Huayuan Tian's Hospital,Jinhua Zhejiang 322121,China;Jinhua Municipal Central Hospital,Jinhua Zhejiang 321099,China)
出处 《新中医》 CAS 2024年第14期75-79,共5页 New Chinese Medicine
关键词 慢性阻塞性肺疾病 急性加重期 痰浊蕴肺证 宣肺化痰汤 中医证候 肺功能 炎症指标 Chronic obstructive pulmonary disease Acute exacerbation Syndrome of turbid phlegm accumulation in the lung Xuanfei Huatan Decoction Traditional Chinese medicine syndrome Lung function Inflammatory indicator
  • 相关文献

参考文献17

二级参考文献293

共引文献3644

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部